• 1
    Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
  • 2
    Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714.
  • 3
    Seef LB. Natural history of chronic hepatitis C. HEPATOLOGY 2002; 36: S35-S46.
  • 4
    Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103: 2727-2736; quiz, 2737.
    Direct Link:
  • 5
    Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part III: liver, biliary tract, and pancreas. Gastroenterology 2009; 136: 1134-1144.
  • 6
    Cheung R, Mannalithara A, Singh G. Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US. Dig Dis Sci 2010; 55: 1744-1751.
  • 7
    Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998; 47: 1-39.
  • 8
    Volk ML, Tocco R, Saini S, Lok AS. Public health impact of antiviral therapy for hepatitis C in the United States. HEPATOLOGY 2009; 50: 1750-1755.
  • 9
    Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey (NHANES) Available at: 2009. Accessed on March 8, 2011.
  • 10
    Centers for Disease Control and Prevention. Documentation, Codebook and Frequencies: Hepatitis C Follow-up Questionnaire, Analytic Notes. Available at:–2008/HCQ_E.htm Accessed on July 15, 2010.
  • 11
    SAS Institute, Inc. SAS/STAT User's Guide, Version 9. Cary, NC: SAS Institute, Inc.; 2009.
  • 12
    Shehab TM, Orrego M, Chunduri R, Lok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol 2003; 98: 639-644.
    Direct Link:
  • 13
    Navarro VJ, St Louis TE, Bell BP. Identification of patients with hepatitis C virus infection in New Haven County primary care practices. J Clin Gastroenterol 2003; 36: 431-435.
  • 14
    Schuckman H, Hazelett S, Powell C, Steer S. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache. Subst Use Misuse 2008; 43: 589-595.
  • 15
    Chou R, Clark EC, Helfand M. Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004; 140: 465-479.
  • 16
    Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? HEPATOLOGY 2010; 52: 1497-1505.
  • 17
    IOM (Institute of Medicine). Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: National Academies Press; 2010. Available at: Accessed on March 8, 2011.